Evaluation of blueberry juice in mouse azoxymethane-induced aberrant crypts and oxidative damage. 2014

Isela Alvarez-González, and Fernando Garcia-Melo, and Verónica R Vásquez-Garzón, and Saúl Villa-Treviño, and E Osiris Madrigal-Santillán, and José A Morales-González, and Jorge A Mendoza-Pérez, and Eduardo Madrigal-Bujaidar
Laboratorio de Genética, Escuela Nacional de Ciencias Biológicas, IPN, Unidad Profesional A. López Mateos, Avenida Wilfredo Massieu s/n, Zacatenco, Colonia, Lindavista, CP 07738, México, DF, Mexico.

Blueberry is a plant with a number of nutritional and biomedical capabilities. In the present study we initially evaluated the capacity of its juice (BJ) to inhibit the number of aberrant crypts (AC) induced with azoxymethane (AOM) in mouse. BJ was administered daily by the oral route to three groups of animals during four weeks (1.6, 4.1, and 15.0 μL/g), respectively, while AOM (10 mg/kg) was intraperitoneally injected to the mentioned groups, twice a week, in weeks two and three of the assay. We also included two control groups of mice, one administered distilled water and the other the high dose of BJ. A significant increase of AC was observed in the AOM treated animals, and a mean protection of 75.6% was determined with the two low doses of BJ tested; however, the high dose of the juice administered together with AOM increased the number of crypts more than four times the value observed in animals administered only AOM. Furthermore, we determined the antioxidant potential of BJ with an ex vivo DPPH assay and found a dose-dependent decrease with a mean of 19.5%. We also determined the DNA oxidation/antioxidation by identifying 8-hydroxy-2'-deoxyguanosine adducts and found a mean decrease of 44.3% with the BJ administration with respect to the level induced by AOM. Our results show a complex differential effect of BJ related to the tested doses, opening the need to further evaluate a number of factors so as to determine the possibility of a cocarcinogenic potential.

UI MeSH Term Description Entries

Related Publications

Isela Alvarez-González, and Fernando Garcia-Melo, and Verónica R Vásquez-Garzón, and Saúl Villa-Treviño, and E Osiris Madrigal-Santillán, and José A Morales-González, and Jorge A Mendoza-Pérez, and Eduardo Madrigal-Bujaidar
October 2015, Pharmacognosy magazine,
Isela Alvarez-González, and Fernando Garcia-Melo, and Verónica R Vásquez-Garzón, and Saúl Villa-Treviño, and E Osiris Madrigal-Santillán, and José A Morales-González, and Jorge A Mendoza-Pérez, and Eduardo Madrigal-Bujaidar
November 2000, Cancer letters,
Isela Alvarez-González, and Fernando Garcia-Melo, and Verónica R Vásquez-Garzón, and Saúl Villa-Treviño, and E Osiris Madrigal-Santillán, and José A Morales-González, and Jorge A Mendoza-Pérez, and Eduardo Madrigal-Bujaidar
December 1991, Cancer letters,
Isela Alvarez-González, and Fernando Garcia-Melo, and Verónica R Vásquez-Garzón, and Saúl Villa-Treviño, and E Osiris Madrigal-Santillán, and José A Morales-González, and Jorge A Mendoza-Pérez, and Eduardo Madrigal-Bujaidar
June 1996, Carcinogenesis,
Isela Alvarez-González, and Fernando Garcia-Melo, and Verónica R Vásquez-Garzón, and Saúl Villa-Treviño, and E Osiris Madrigal-Santillán, and José A Morales-González, and Jorge A Mendoza-Pérez, and Eduardo Madrigal-Bujaidar
January 1990, The American journal of pathology,
Isela Alvarez-González, and Fernando Garcia-Melo, and Verónica R Vásquez-Garzón, and Saúl Villa-Treviño, and E Osiris Madrigal-Santillán, and José A Morales-González, and Jorge A Mendoza-Pérez, and Eduardo Madrigal-Bujaidar
May 1994, Carcinogenesis,
Isela Alvarez-González, and Fernando Garcia-Melo, and Verónica R Vásquez-Garzón, and Saúl Villa-Treviño, and E Osiris Madrigal-Santillán, and José A Morales-González, and Jorge A Mendoza-Pérez, and Eduardo Madrigal-Bujaidar
September 1992, Carcinogenesis,
Isela Alvarez-González, and Fernando Garcia-Melo, and Verónica R Vásquez-Garzón, and Saúl Villa-Treviño, and E Osiris Madrigal-Santillán, and José A Morales-González, and Jorge A Mendoza-Pérez, and Eduardo Madrigal-Bujaidar
August 2001, Molecular carcinogenesis,
Isela Alvarez-González, and Fernando Garcia-Melo, and Verónica R Vásquez-Garzón, and Saúl Villa-Treviño, and E Osiris Madrigal-Santillán, and José A Morales-González, and Jorge A Mendoza-Pérez, and Eduardo Madrigal-Bujaidar
September 1996, Carcinogenesis,
Isela Alvarez-González, and Fernando Garcia-Melo, and Verónica R Vásquez-Garzón, and Saúl Villa-Treviño, and E Osiris Madrigal-Santillán, and José A Morales-González, and Jorge A Mendoza-Pérez, and Eduardo Madrigal-Bujaidar
January 2008, Experimental biology and medicine (Maywood, N.J.),
Copied contents to your clipboard!